{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T16:50:37Z","timestamp":1778172637835,"version":"3.51.4"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.exer.2015.10.008","type":"journal-article","created":{"date-parts":[[2015,10,22]],"date-time":"2015-10-22T18:01:11Z","timestamp":1445536871000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Sj\u00f6gren's syndrome associated dry eye in a mouse model is ameliorated by topical application of integrin \u03b14 antagonist GW559090"],"prefix":"10.1016","volume":"143","author":[{"given":"Laura","family":"Contreras-Ruiz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fayaz A.","family":"Mir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9470-1075","authenticated-orcid":false,"given":"Bruce","family":"Turpie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9347-8745","authenticated-orcid":false,"given":"Achim H.","family":"Krauss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharmila","family":"Masli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.exer.2015.10.008_bib1","first-page":"1004","article-title":"Decreased levels of the goblet cell mucin MUC5AC in tears of patients with Sjogren syndrome","volume":"43","author":"Argueso","year":"2002","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2015.10.008_bib2","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0002-9394(03)00326-X","article-title":"The comparison of efficacies of topical corticosteroids and nonsteroidal anti-inflammatory drops on dry eye patients: a clinical and immunocytochemical study","volume":"136","author":"Avunduk","year":"2003","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.exer.2015.10.008_bib3","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.2353\/ajpath.2010.100227","article-title":"Interleukin-1 as a phenotypic immunomodulator in keratinizing squamous metaplasia of the ocular surface in Sjogren's syndrome","volume":"177","author":"Chen","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.exer.2015.10.008_bib4","doi-asserted-by":"crossref","first-page":"e75937","DOI":"10.1371\/journal.pone.0075937","article-title":"Conjunctival inflammation in thrombospondin-1 deficient mouse model of Sjogren's syndrome","volume":"8","author":"Contreras-Ruiz","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.exer.2015.10.008_bib5","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/j.ophtha.2014.01.033","article-title":"Polymorphism in THBS1 gene is associated with post-refractive surgery chronic ocular surface inflammation","volume":"121","author":"Contreras-Ruiz","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2015.10.008_bib6","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1084\/jem.20092277","article-title":"Thrombospondin 1 inhibits inflammatory lymphangiogenesis by CD36 ligation on monocytes","volume":"208","author":"Cursiefen","year":"2011","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.exer.2015.10.008_bib7","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1517\/14712598.3.1.85","article-title":"Adhesion molecules as therapeutic targets for autoimmune diseases and transplant rejection","volume":"3","author":"Dedrick","year":"2003","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.exer.2015.10.008_bib8","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1001\/archopht.126.12.1695","article-title":"Modulation of integrin alpha4beta1 (VLA-4) in dry eye disease","volume":"126","author":"Ecoiffier","year":"2008","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.exer.2015.10.008_bib9","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1177\/1756283X10373176","article-title":"Anti-adhesion molecule therapy for inflammatory bowel disease","volume":"3","author":"Ghosh","year":"2010","journal-title":"Ther. Adv. Gastroenterol."},{"key":"10.1016\/j.exer.2015.10.008_bib10","doi-asserted-by":"crossref","first-page":"4724","DOI":"10.4049\/jimmunol.175.7.4724","article-title":"A\u00a0small molecule alpha 4 beta 1 antagonist prevents development of murine Lyme arthritis without affecting protective immunity","volume":"175","author":"Glasner","year":"2005","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.exer.2015.10.008_bib11","first-page":"757","article-title":"Review. Leukocyte and endothelial cell adhesion molecules in inflammation focusing on inflammatory heart disease","volume":"21","author":"Golias","year":"2007","journal-title":"In\u00a0Vivo"},{"key":"10.1016\/j.exer.2015.10.008_bib12","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1021\/jm060031q","article-title":"Synthesis and biological evaluation of novel pyridazinone-based alpha4 integrin receptor antagonists","volume":"49","author":"Gong","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.exer.2015.10.008_bib13","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1001\/archophthalmol.2010.124","article-title":"Evidence of corneal lymphangiogenesis in dry eye disease: a potential link to adaptive immunity?","volume":"128","author":"Goyal","year":"2010","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.exer.2015.10.008_bib14","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1167\/iovs.08-2606","article-title":"Interleukin-1beta-induced disruption of barrier function in cultured human corneal epithelial cells","volume":"50","author":"Kimura","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2015.10.008_bib15","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1034\/j.1600-0609.2002.02657.x","article-title":"Macrophage-dependent regulation of neutrophil mobilization and chemotaxis during development of sterile peritonitis in the rat","volume":"69","author":"Knudsen","year":"2002","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.exer.2015.10.008_bib16","doi-asserted-by":"crossref","first-page":"5888","DOI":"10.1167\/iovs.15-17249","article-title":"Improvement of outcome measures of dry eye by a novel integrin antagonist in the murine desiccating stress model","volume":"56","author":"Krauss","year":"2015","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2015.10.008_bib17","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1001\/archopht.120.3.330","article-title":"Goblet cell numbers and epithelial proliferation in the conjunctiva of patients with dry eye syndrome treated with cyclosporine","volume":"120","author":"Kunert","year":"2002","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.exer.2015.10.008_bib18","first-page":"221","article-title":"Report of the National Eye Institute\/Industry workshop on clinical trials in dry eyes","volume":"21","author":"Lemp","year":"1995","journal-title":"CLAO J."},{"key":"10.1016\/j.exer.2015.10.008_bib19","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1167\/iovs.09-4677","article-title":"Molecular mechanism of proinflammatory cytokine-mediated squamous metaplasia in human corneal epithelial cells","volume":"51","author":"Li","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2015.10.008_bib20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1056\/NEJMoa020696","article-title":"A\u00a0controlled trial of natalizumab for relapsing multiple sclerosis","volume":"348","author":"Miller","year":"2003","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.exer.2015.10.008_bib21","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1076\/ceyr.19.3.201.5309","article-title":"Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjogren's syndrome keratoconjunctivitis sicca","volume":"19","author":"Pflugfelder","year":"1999","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.exer.2015.10.008_bib22","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0025-6196(11)62408-7","article-title":"Incidence of physician-diagnosed primary Sjogren syndrome in residents of Olmsted County, Minnesota","volume":"76","author":"Pillemer","year":"2001","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.exer.2015.10.008_bib23","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1056\/NEJMoa044397","article-title":"A\u00a0randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis","volume":"354","author":"Polman","year":"2006","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.exer.2015.10.008_bib24","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1111\/j.1398-9995.2006.01146.x","article-title":"The effect of a single inhaled dose of a VLA-4 antagonist on allergen-induced airway responses and airway inflammation in patients with asthma","volume":"61","author":"Ravensberg","year":"2006","journal-title":"Allergy"},{"key":"10.1016\/j.exer.2015.10.008_bib25","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/jcla.1860070309","article-title":"Expression of cell adhesion molecules in the salivary and lacrimal glands of Sjogren's syndrome","volume":"7","author":"Saito","year":"1993","journal-title":"J.\u00a0Clin. Lab. Anal."},{"key":"10.1016\/j.exer.2015.10.008_bib26","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s100670050109","article-title":"Adhesion and lymphocyte costimulatory molecules in systemic rheumatic diseases","volume":"18","author":"Sfikakis","year":"1999","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.exer.2015.10.008_bib27","first-page":"2283","article-title":"Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease","volume":"42","author":"Solomon","year":"2001","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2015.10.008_bib28","first-page":"2609","article-title":"Conjunctival T-cell subpopulations in Sjogren's and non-Sjogren's patients with dry eye","volume":"43","author":"Stern","year":"2002","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2015.10.008_bib29","doi-asserted-by":"crossref","first-page":"4464","DOI":"10.1182\/blood-2003-03-0974","article-title":"Differential effects of treatment with a small-molecule VLA-4 antagonist before and after onset of relapsing EAE","volume":"102","author":"Theien","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.exer.2015.10.008_bib30","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.2353\/ajpath.2009.081058","article-title":"Sjogren's syndrome-like ocular surface disease in thrombospondin-1 deficient mice","volume":"175","author":"Turpie","year":"2009","journal-title":"Am. J. Pathol."}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483515300476?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483515300476?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T09:53:06Z","timestamp":1537264386000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483515300476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":30,"alternative-id":["S0014483515300476"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2015.10.008","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sj\u00f6gren's syndrome associated dry eye in a mouse model is ameliorated by topical application of integrin \u03b14 antagonist GW559090","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2015.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}